BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, May 11, 2026
Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Targeted Genetics Regains CF Program From Celltech

Dec. 5, 2002
By Aaron Lorenzo

Ricerca Broadens Drug Program, Gains Lilly Antibacterial Targets

Dec. 5, 2002
By Aaron Lorenzo

Targeted Genetics Regains CF Program From Celltech

Dec. 5, 2002
By Aaron Lorenzo

MGI Raises $21M For Palonosetron Milestone Payments To Helsinn

Dec. 3, 2002
By Aaron Lorenzo
MGI Pharma Inc. on Monday lined its pockets with $21 million in a private placement, funding sufficient to cover two remaining milestone payments as part of a license agreement with Helsinn Healthcare SA. (BioWorld Today)
Read More

MGI Raises $21M For Palonosetron Milestone Payments To Helsinn

Dec. 3, 2002
By Aaron Lorenzo
MGI Pharma Inc. on Monday lined its pockets with $21 million in a private placement, funding sufficient to cover two remaining milestone payments as part of a license agreement with Helsinn Healthcare SA. (BioWorld Today)
Read More

Predix Pushing Computational Technology To ID Candidates

Dec. 2, 2002
By Aaron Lorenzo

Predix Pushing Computational Technology To ID Candidates

Dec. 2, 2002
By Aaron Lorenzo

Surface Logix Completes $25M Round For Drug Discovery Work

Nov. 27, 2002
By Aaron Lorenzo

IDDS, eXegenics Merger Falls Through; Reason Not Disclosed

Nov. 27, 2002
By Aaron Lorenzo

IDDS, eXegenics Merger Falls Through; Reason Not Disclosed

Nov. 27, 2002
By Aaron Lorenzo
Previous 1 2 … 214 215 216 217 218 219 220 221 222 … 237 238 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 11, 2026.
  • Rendering of a key measles protein targeted by neutralizing human antibodies

    First measles treatment advances as vaccination rates drop

    BioWorld
    Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
  • Infensa Bioscience identifies new ASIC blockers

    BioWorld Science
    Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
  • Close up of bow of cruise ship

    Hantavirus is ‘sentinel’ more than acute pandemic threat

    BioWorld
    News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
  • Neurology illustration

    Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst

    BioWorld
    Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing